Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy of Pagibaximab Injection in Very Low Birth Weight Neonates for Prevention of Staphylococcal Sepsis
This study is currently recruiting participants.
Study NCT00646399   Information provided by Biosynexus Incorporated
First Received: March 26, 2008   Last Updated: October 7, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Staphylococcal Sepsis
Additional conditions recognized in this trial
Bacteremia
Birth Weight
Sepsis
Staphylococcal Infections
More general conditions related to this trial
Bacterial Infections
Body Weight
Gram-Positive Bacterial Infections
Infection
Inflammation
Pathologic Processes
Signs and Symptoms
Systemic Inflammatory Response Syndrome
Interventions listed in this trial
Pagibaximab (formerly BSYX-A110)
Sponsors listed in this trial
Biosynexus Incorporated


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services